GO
Loading...

Enter multiple symbols separated by commas

CNBC's Huckman: More Questions Arise on Drug-Coated Stents

Two studies and an editorial in the journal of the American Medical Association are raising even more questions about the safety of drug-coated stents and could further hurt already-declining sales.

This concerns so-called "off-label" use of drug-coated stents, which actually makes up the majority of procedures. It involves people who are in the throes of a heart attack, have big, multiple blockages or other medical complications.

Researchers say after one year, those patients had double the risk of death versus those who were treated "on-label" or have just one blocked artery.

And one of the studies says it only saw that problem with Boston Scientific's stent and not Johnson & Johnson's, though J&J paid for that study.

The JAMA editorial says doctors shouldn't "succumb to the hope and hype" of drug-coated stents. In fact safety issues and other new studies have led more doctors to switch back to bare metal stents or old-fashioned heart drugs.

J&J and Boston Scientific make the only drug-coated stents on the U.S. market. But Medtronic and Abbott hope to come to market here soon.

Contact U.S. News

  • CNBC NEWSLETTERS

    Get the best of CNBC in your inbox

    Please choose a subscription

    Please enter a valid email address
    To learn more about how we use your information,
    please read our Privacy Policy.

Don't Miss

  • Why women cheat?

    Is cheating bad? Why do women cheat? The founder and CEO of affair website Ashley Madison tells all, including why he has his eye on China.

  • Judge's gavel

    The Financial Industry Regulatory Authority disciplined several financial services firms and individuals in May 2015.

  • Fine wines & finance

    Why you should try something a little different on date night. Bring the romance and champagne, and a calculator too. Every once in a while have a date to talk money and finance, and keep an important part of your relationship on track. Reporter Sharon Epperson talks to a couple who does just that.

U.S. Video

  • Cramer: Here's a sign the market could rally

    Wall Street's been soaking in red, but "Mad Money" host Jim Cramer has one signal to watch for that could point to another run.

  • Burger war maneuvers

    Cramer looks at the number of company's selling burgers and tries to determine the quality names, as well as those to avoid.

  • Cramer: What's driving defense?

    Cramer says that even though President Obama has made it clear the US can no longer be the world's policeman, the country can become the world's arms dealer. Profiting from defense spending.